A team of researchers in the United States has conducted a new study on “bepridil”, a drug identified for the treatment of Covid-19.
As part of research into treatment against the pandemic of coronavirus, a new study is being carried out by a research team from universities Texas A&M and Medical branch.
To the United States, a drug currently on the market to treat angina pectoris, is at the heart of this study. It’s about “bepridil“, this treatment has been approved by the Food and Drug Administration (FDA) for United States to cure this heart disease. Yet it has shown significant efficacy in interfering with the entry of the Covid-19 in the body, reports Yahoo News.
Find alternative medicines
The authors of this study recalled that currently, only one drug is available, Remdesivir, to provide limited benefits to patients of coronavirus.
It is thus imperative, according to them, to find alternative medicines. “Our team has reviewed over 30 drugs approved by the FDA / European Medicines Agency for their ability to inhibit entry of SARS-COV-2 into human cells.“, they explained.
Better processing potential
The results of this study demonstrated that the “bepridil“offers the best treatment potential for Covid-19.
Specialists have therefore proposed to take into account the use of this drug in clinical tests related to this disease. The team plans to advance their work towards animal models with potential for clinical trials. The conclusions of this study will be published on March 9.
> To read also: The United States has passed the milestone of 500,000 deaths linked to the coronavirus